BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7705933)

  • 1. Multiple forms of cathepsin B in human lung cancer.
    Krepela E; Procházka J; Mynaríková H; Kárová B; Polák J; Cermák J; Roubková H
    Int J Cancer; 1995 Mar; 61(1):44-53. PubMed ID: 7705933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma.
    Krepela E; Procházka J; Mynaríková H; Kárová B; Cermák J; Roubková H
    Neoplasma; 1996; 43(3):171-8. PubMed ID: 8841504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1997; 44(4):219-39. PubMed ID: 9473776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
    Werle B; Jülke B; Lah T; Spiess E; Ebert W
    Br J Cancer; 1997; 75(8):1137-43. PubMed ID: 9099961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cathepsin B activity in human lung tumors.
    Krepela E; Kasafírek E; Novák K; Viklický J
    Neoplasma; 1990; 37(1):61-70. PubMed ID: 2320181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma.
    Sedo A; Krepela E; Kasafírek E
    J Cancer Res Clin Oncol; 1991; 117(3):249-53. PubMed ID: 1674512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charge polymorphism in human lung cell pro-cathepsin B.
    Werle B; Ebert W; Klein W; Spiess E
    Anticancer Res; 1996; 16(1):49-53. PubMed ID: 8615660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients.
    Lüthgens K; Ebert W; Trefz G; Gabrijelcic D; Turk V; Lah T
    Cancer Detect Prev; 1993; 17(3):387-97. PubMed ID: 8402725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.
    Spiess E; Brüning A; Gack S; Ulbricht B; Spring H; Trefz G; Ebert W
    J Histochem Cytochem; 1994 Jul; 42(7):917-29. PubMed ID: 8014475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated activities and properties of arylsulfatases A and B and B-variant in human lung tumors.
    Gasa S; Makita A; Kameya T; Kodama T; Araki E; Yoneyama T; Hirama M; Hashimoto M
    Cancer Res; 1980 Oct; 40(10):3804-9. PubMed ID: 7438063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [beta-Glucuronidase in human maxillary sinus and lung cancers: elevation of activity level and appearance of phosphorylated variant forms].
    Fujita M
    Hokkaido Igaku Zasshi; 1984 Sep; 59(5):622-38. PubMed ID: 6096243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzymatic studies on human carcinoma tissues,--especially, study on beta-N-acetylhexosaminidases in oral and pulmonary carcinomas].
    Narita M
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):683-98. PubMed ID: 2934309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on charge heterogeneity of arylsulfatase A from human lung cancer].
    Nakamura M
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):671-82. PubMed ID: 2867024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
    Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
    Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence demonstration of cathepsin B-like cysteine proteinase activity in lung squamous cell carcinomas and surrounding tissues.
    Kolár Z
    Acta Univ Palacki Olomuc Fac Med; 1986; 114():203-9. PubMed ID: 2946180
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer-associated alteration of beta-glucuronidase in human lung cancer: elevated activity and increased phosphorylation.
    Fujita M; Taniguchi N; Makita A; Oikawa K
    Gan; 1984 Jun; 75(6):508-17. PubMed ID: 6432619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of cathepsin B in two human lung cancer cell lines.
    Erdel M; Trefz G; Spiess E; Habermaas S; Spring H; Lah T; Ebert W
    J Histochem Cytochem; 1990 Sep; 38(9):1313-21. PubMed ID: 2201737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer.
    Sukoh N; Abe S; Ogura S; Isobe H; Takekawa H; Inoue K; Kawakami Y
    Cancer; 1994 Jul; 74(1):46-51. PubMed ID: 8004582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.